Cargando…

Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2

We have shown earlier that Kir2 channels are suppressed by the elevation of membrane cholesterol. Moreover, it is also well known that activation of Kir channels is critically dependent on a regulatory phospholipid, phosphatidylinositol-4,5-bisphosphate (PIP2). In this study we examined the cross-ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenhouse-Dantsker, Avia, Epshtein, Yulia, Levitan, Irena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232564/
https://www.ncbi.nlm.nih.gov/pubmed/25408847
http://dx.doi.org/10.1016/j.csbj.2014.09.007
_version_ 1782344588631998464
author Rosenhouse-Dantsker, Avia
Epshtein, Yulia
Levitan, Irena
author_facet Rosenhouse-Dantsker, Avia
Epshtein, Yulia
Levitan, Irena
author_sort Rosenhouse-Dantsker, Avia
collection PubMed
description We have shown earlier that Kir2 channels are suppressed by the elevation of membrane cholesterol. Moreover, it is also well known that activation of Kir channels is critically dependent on a regulatory phospholipid, phosphatidylinositol-4,5-bisphosphate (PIP2). In this study we examined the cross-talk between cholesterol and PIP2 in the regulation of Kir2 channels. The strength of Kir2–PIP2 interactions was assessed by acute sequestering of PIP2 with neomycin dialyzed into cells through a patch pipette while simultaneously recording whole cell currents. Consistent with a reduction in PIP2 levels, dialysis of neomycin resulted in a decrease in Kir2.1 and Kir2.3 current amplitudes (current rundown), however, this effect was significantly delayed by cholesterol depletion for both types of channels suggesting that cholesterol depletion strengthens the interaction between Kir2 channels and PIP2. Furthermore, mutation of Kir2.1 that renders the channels' cholesterol insensitive abrogated cholesterol depletion-induced delay in the current rundown whereas reverse mutation in Kir2.3 has the opposite effect. These observations provide further support for the functional cross-talk between cholesterol and PIP2 in regulating Kir2 channels. Consistent with these observations, there is a significant structural overlap between cytosolic residues that are critical for the sensitivity of Kir2 channels to the two lipid modulators but based on recent studies, there is little or no overlap between cholesterol and PIP2 binding sites. Taken together, these observations suggest that cholesterol and PIP2 regulate the channels through distinct binding sites but that the signals generated by the binding of the two modulators converge.
format Online
Article
Text
id pubmed-4232564
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Research Network of Computational and Structural Biotechnology
record_format MEDLINE/PubMed
spelling pubmed-42325642014-11-18 Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2 Rosenhouse-Dantsker, Avia Epshtein, Yulia Levitan, Irena Comput Struct Biotechnol J Article We have shown earlier that Kir2 channels are suppressed by the elevation of membrane cholesterol. Moreover, it is also well known that activation of Kir channels is critically dependent on a regulatory phospholipid, phosphatidylinositol-4,5-bisphosphate (PIP2). In this study we examined the cross-talk between cholesterol and PIP2 in the regulation of Kir2 channels. The strength of Kir2–PIP2 interactions was assessed by acute sequestering of PIP2 with neomycin dialyzed into cells through a patch pipette while simultaneously recording whole cell currents. Consistent with a reduction in PIP2 levels, dialysis of neomycin resulted in a decrease in Kir2.1 and Kir2.3 current amplitudes (current rundown), however, this effect was significantly delayed by cholesterol depletion for both types of channels suggesting that cholesterol depletion strengthens the interaction between Kir2 channels and PIP2. Furthermore, mutation of Kir2.1 that renders the channels' cholesterol insensitive abrogated cholesterol depletion-induced delay in the current rundown whereas reverse mutation in Kir2.3 has the opposite effect. These observations provide further support for the functional cross-talk between cholesterol and PIP2 in regulating Kir2 channels. Consistent with these observations, there is a significant structural overlap between cytosolic residues that are critical for the sensitivity of Kir2 channels to the two lipid modulators but based on recent studies, there is little or no overlap between cholesterol and PIP2 binding sites. Taken together, these observations suggest that cholesterol and PIP2 regulate the channels through distinct binding sites but that the signals generated by the binding of the two modulators converge. Research Network of Computational and Structural Biotechnology 2014-09-28 /pmc/articles/PMC4232564/ /pubmed/25408847 http://dx.doi.org/10.1016/j.csbj.2014.09.007 Text en © 2014 Rosenhouse-Dantsker et al. on behalf of the Research Network of Computational and Structural Biotechnology.
spellingShingle Article
Rosenhouse-Dantsker, Avia
Epshtein, Yulia
Levitan, Irena
Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2
title Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2
title_full Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2
title_fullStr Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2
title_full_unstemmed Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2
title_short Interplay Between Lipid Modulators of Kir2 Channels: Cholesterol and PIP2
title_sort interplay between lipid modulators of kir2 channels: cholesterol and pip2
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232564/
https://www.ncbi.nlm.nih.gov/pubmed/25408847
http://dx.doi.org/10.1016/j.csbj.2014.09.007
work_keys_str_mv AT rosenhousedantskeravia interplaybetweenlipidmodulatorsofkir2channelscholesterolandpip2
AT epshteinyulia interplaybetweenlipidmodulatorsofkir2channelscholesterolandpip2
AT levitanirena interplaybetweenlipidmodulatorsofkir2channelscholesterolandpip2